Form 8-K - Current report:
SEC Accession No. 0001437749-14-016883
Filing Date
2014-09-11
Accepted
2014-09-11 16:05:06
Documents
29
Period of Report
2014-09-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ombp20140911_8k.htm 8-K 21149
2 EXHIBIT 99.1 ex99-1.htm EX-99 17162
3 a27.jpg GRAPHIC 163438
4 a26.jpg GRAPHIC 141726
5 a25.jpg GRAPHIC 147479
6 a24.jpg GRAPHIC 167695
7 a23.jpg GRAPHIC 142761
8 a22.jpg GRAPHIC 176903
9 a21.jpg GRAPHIC 125412
10 a20.jpg GRAPHIC 342060
11 a19.jpg GRAPHIC 131041
12 a18.jpg GRAPHIC 192623
13 a17.jpg GRAPHIC 146927
14 a16.jpg GRAPHIC 60798
15 a15.jpg GRAPHIC 183194
16 a14.jpg GRAPHIC 152290
17 a13.jpg GRAPHIC 192316
18 a12.jpg GRAPHIC 143261
19 a11.jpg GRAPHIC 181225
20 a10.jpg GRAPHIC 171244
21 a9.jpg GRAPHIC 130265
22 a8.jpg GRAPHIC 140384
23 a7.jpg GRAPHIC 166423
24 a6.jpg GRAPHIC 184271
25 a5.jpg GRAPHIC 142322
26 a4.jpg GRAPHIC 184488
27 a3.jpg GRAPHIC 170956
28 a2.jpg GRAPHIC 172112
29 a1.jpg GRAPHIC 123591
  Complete submission text file 0001437749-14-016883.txt   6073326
Mailing Address 181 W BOARDWALK DRIVE SUITE 202 FORT COLLINS CO 80525
Business Address 181 W BOARDWALK DRIVE SUITE 202 FORT COLLINS CO 80525 970-237-5178
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-52530 | Film No.: 141098239
SIC: 2836 Biological Products, (No Diagnostic Substances)